Ctsd — Cathepsin D is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
CTSD encodes cathepsin D, a lysosomal aspartyl protease that plays essential roles in protein degradation, autophagy, and cell survival. It is one of the major lysosomal proteases and is implicated in various neurodegenerative diseases.
Cathepsin D is a hydrolytic enzyme localized primarily to lysosomes where it degrades proteins, peptides, and lipids. It is synthesized as a preproenzyme (52 kDa) and processed to the mature form (34 kDa + 14 kDa) through the secretory pathway. Beyond lysosomal degradation, cathepsin D participates in antigen processing, apoptosis regulation, and amyloid precursor protein processing.
| Attribute | Value |
|---|---|
| Gene Symbol | CTSD |
| Chromosomal Location | 11p15.5 |
| NCBI Gene ID | 1509 |
| Uniprot ID | P07339 |
| Aliases | CLN10, CPSD |
| Protein Name | Cathepsin D |
Cathepsin D structure:
Catalytic mechanism involves two aspartic acid residues in the active site.
CTSD encodes Cathepsin D, an aspartyl protease that degrades proteins in lysosomes. It plays critical roles in protein turnover and has been implicated in neurodegenerative diseases.
Cathepsin D degrades:
Essential for proper autophagic function:
Cathepsin D can process amyloid precursor protein:
Dysregulated cathepsin D can:
Cathepsin D in AD:
CLN10 disease:
Cathepsin D is overexpressed in many cancers:
Wide tissue distribution:
| Strategy | Approach | Status |
|---|---|---|
| Enhancement | Increase cathepsin D activity | Preclinical |
| Inhibition | Block in cancer | Clinical (cancer) |
| Gene therapy | Restore function (CLN10) | Experimental |
Cathepsin D is a lysosomal aspartyl protease that:
Cathepsin D is implicated in:
Cathepsin D inhibitors are being investigated as potential AD therapeutics. However, its role in normal brain function makes complete inhibition challenging.
The study of Ctsd — Cathepsin D has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.